The predictive value of neutrophil to lymphocyte ratio and mean platelet volume on acute kidney injury after TAVI
DOI:
https://doi.org/10.33308/2687248X.202243280Keywords:
Acute kidney injury, transcatheter aortic valve replacement, neutrophil, lymphocyte, mean platelet volumeAbstract
Objective: Transcatheter aortic valve implantation (TAVI) is an effective treatment for severe aortic stenosis. Acute kidney injury (AKI) is a common complication after TAVI. The development of AKI after TAVI has been linked to the thromboinflammatory response as evaluated by the neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume (MPV). We sought to determine the predictive value of NLR and MPV on AKI after TAVI in this study. Method: This is a single-center retrospective study. Baseline, peri-procedural, and post-procedural demographic, laboratory, and clinical characteristics were assessed for AKI. The optimal NLR and MPV cut-off values for predicting AKI were determined using receiver operating characteristic (ROC) curve analysis. Results: A total of 184 consecutive patients (age 79.4 ± 7.8 years, 61.4% female) who underwent TAVI were included in this study. The optimal cut-off points for the NLR and MPV were 5.70 (AUC: 0.790; 95% CI: 0.711-0.869, p<0.001 and sensitivity= 80.0%, specificity= 65.2%) and 9.15 fL (AUC:0.713; 95% CI: 0.629-0.997, p<0.001 and sensitivity=70.7%, specificity=63.6%), respectively. AKI occurred in 41 (22.3%) patients included in the study and 6 (3.3%) required dialysis. Baseline GFR (OR: 0.98; 95% CI: 0.94-0.99, p = 0.001), post-procedural WBC count (OR: 1.17; 95% CI: 1.03-1.33, p= 0.02), post-procedural NLR≥ 5.7 (OR: 5.16; 95% CI: 1.84-14.48, p= 0.002), and post-procedural MPV ≥ 9.15 fL (OR: 3.70; 95% CI: 1.54–8.91, p= 0.004) were found to be the independent predictors of AKI after TAVI in multivariable analysis. Conclusion: Post-procedural NLR and MPV were found to be independent predictors of AKI after TAVI.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Health and Life Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
